A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder

Exclusion Criteria

• •Participants who meet any of the following criteria will not be eligible for inclusion in this study:
• •1. Thickness of gallbladder wall is larger than 6 mm.
• •2. Clinically diagnosed as gallbladder cancer.
• •3. Clinically diagnosed as gallbladder and/or bile duct stones, and/or acute cholecystitis.
• •4. Previously performed gallbladder/biliary tract related operations, such as gallbladder-protected lithotomy, ERCP lithotomy, PTCS lithotomy and PTGBD.
• •5. Have severe infectious or severe primary diseases such as diseases in cardiovascular, cerebrovascular, pulmonary, renal or endocrine or hematopoietic system, or with mental diseases and/or behavioral abnormalities, which cannot be enrolled in the study determined by investigator.
• •6. Have irregular stool, and/or daily stool frequency more than or equal to 5 times in recent 2 weeks.
• •7. Regularly taken any Chinese patent medicine (including traditional Chinese medicine injection) with "soothing liver, cholagogic, clearing heat, dredging intestines" clearly written in the instructions, or regularly taken the traditional Chinese medicine decoction with the effect of soothing liver and cholagogic in recent 4 weeks.
• •8. Regularly taken proton pump inhibitors or H2 receptor antagonists or cholinergic receptor antagonists or gastrin receptor antagonists in recent 4 weeks.
• •9. Allergic to Danning Tablet and its components, has history of allergy, or has allergic constitution, or in allergic state.
• •10. Are pregnant, planning to be pregnant or breastfeeding.
• •11. Poor compliance, unable to cooperate with the investigator;
• •12. Have previously been involved in another clinical trial in the past three month;
• •13. Other situations not suitable for inclusion.